Harvest Group Wealth Management, LLC Ligand Pharmaceuticals Inc Transaction History

Harvest Group Wealth Management, LLC

  • $154 Million
  • Q1 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 23, 2020
SELL
$63.37 - $107.88 $887 - $1,510
-14 Closed
0 $0
Q4 2019

Jan 27, 2020
BUY
$96.94 - $113.59 $1,357 - $1,590
14 New
14 $1,000
Q3 2019

Nov 01, 2019
SELL
$86.25 - $120.16 $1,897 - $2,643
-22 Closed
0 $0
Q1 2019

May 06, 2019
BUY
$105.93 - $142.47 $2,330 - $3,134
22 New
22 $3,000

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.07B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Harvest Group Wealth Management, LLC Portfolio

Follow Harvest Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email